Self-Administered Drugs Market By Product type (Injectable drugs, Inhaled drugs), Mode of administration (Oral, Transdermal, Intravenous, Nasal), Application (Diabetes, Hormone replacement, Cardiovascular ailment, Pain management, Osteoporosis, Others), Industry Trends, Estimation & Forecast, 2017 - 2025

This report studies Self-Administered Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2025.

Drugs administered by the patients without the help of medical professionals are referred to as self-administered drugs. Self-administered drugs such as topical prescription drugs, over-the-counter drugs, and self-administered intravenous drugs are mainly consumed by patients suffering from chronic diseases such as multiple sclerosis, rheumatoid arthritis, diabetes and others. The rising prevalence of chronic diseases globally is expected to boost the demand for self-administered drugs, mainly among the geriatric and working populace. As per WHO, by 2050, the world’s aged population (60 years and older) is expected to reach the 2 billion mark, up from 900 million in 2015.

Market Determinants

The key factor driving the growth of global self-administered drugs market is the increasing outpatient services. The changing life style of people encourages them to opt for outpatient services, which in turn fuels the market growth. Moreover, the rising number of diabetic patients, and the government insurance organizations are also driving the growth of global self-administered drugs market. According to WHO, 422 million adults have diabetes worldwide. Such a huge pool of diabetic patients is expected to increase the demand for self-administered drugs. On the other hand, side effects caused due to improper dosage, along with low or zero reimbursement are hindering the market of self-administered drugs. However, innovations in medical science, and increasing awareness regarding self-administered drugs are expected to create huge opportunities for the growth of market in the upcoming years.


By Product Type • Injectable drugs • Inhaled drugs By Mode of Administration • Oral • Transdermal • Intravenous • Nasal By Application • Diabetes • Hormone replacement • Cardiovascular ailment • Pain management • Osteoporosis • Others By Geography • North America • Europe • Asia-Pacific • Rest of the World

Table of Content

• Novartis AG
• Bristol-Mayers Squibb
• Gilead Sciences
• Eli Lilly & Company
• Pfizer, Inc.
• Abbott Laboratories
• Antares Pharma, Inc.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments